The "Lopez vs. Lopez" star shared how symptoms of polycystic ovary syndrome made her depressed and "very self-conscious" ...

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 6% of this population. [1] The clinical issues in PCOS relate to ...

PCOS affects 1 in 10 women of reproductive age, causing irregular periods, excess androgen levels, and ovarian cysts. It ...

A woman diagnosed with polycystic ovaries was left feeling there was “no hope” of becoming a mother – but now has two miracle ...

PCOS is one of the most common disorders affecting women of reproductive age. As a syndrome, it has multiple components, including reproductive, metabolic, and cardiovascular, with long-term ...

India: A recent pilot study has highlighted the potential benefits of yoga in improving insulin resistance among women with ...

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

ADPKD, or autosomal dominant polycystic kidney disease, can cause severe pain, headaches, and more problems. What can you do to feel better and stay active? Find exercise and diet tips ...

Hyperandrogenism is the key pathologic feature of polycystic ovary syndrome, but diagnostic assessment of androgen excess in women is problematic, and the biochemical assays in routine clinical ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.